Symptoms
Common signs and symptoms of Diffuse Large B-Cell Lymphoma include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Diffuse Large B-Cell Lymphoma.
The exact cause of diffuse large B-cell lymphoma remains largely unknown, but scientists understand the basic mechanism behind its development.
The exact cause of diffuse large B-cell lymphoma remains largely unknown, but scientists understand the basic mechanism behind its development. The disease begins when B-cells acquire genetic mutations that disrupt their normal growth and death cycles. These mutations cause the cells to multiply rapidly and live longer than they should, eventually forming tumors in lymph nodes and other organs.
Several factors can increase the likelihood of these harmful mutations occurring.
Several factors can increase the likelihood of these harmful mutations occurring. Certain viral infections, particularly the Epstein-Barr virus and human immunodeficiency virus (HIV), can trigger changes in B-cell behavior. Chronic inflammation from autoimmune conditions like rheumatoid arthritis or inflammatory bowel disease may also create an environment where lymphoma is more likely to develop.
Environmental exposures and immune system problems play additional roles in DLBCL development.
Environmental exposures and immune system problems play additional roles in DLBCL development. Previous chemotherapy or radiation treatments for other cancers can damage DNA and increase lymphoma risk years later. People with compromised immune systems, whether from organ transplant medications or inherited immune deficiencies, face higher odds of developing this type of lymphoma because their bodies cannot effectively eliminate abnormal cells.
Risk Factors
- Age over 60 years
- Male gender
- Weakened immune system from HIV, organ transplant, or inherited disorders
- Previous chemotherapy or radiation treatment
- Infection with Epstein-Barr virus, HIV, or hepatitis C
- Autoimmune diseases like rheumatoid arthritis or lupus
- Family history of lymphoma
- Exposure to certain pesticides or chemicals
- Long-term use of immunosuppressive medications
Diagnosis
How healthcare professionals diagnose Diffuse Large B-Cell Lymphoma:
- 1
Diagnosing diffuse large B-cell lymphoma typically begins when someone notices persistent lymph node swelling or experiences concerning symptoms like unexplained weight loss and night sweats.
Diagnosing diffuse large B-cell lymphoma typically begins when someone notices persistent lymph node swelling or experiences concerning symptoms like unexplained weight loss and night sweats. During the initial examination, doctors feel for enlarged lymph nodes and organs, ask detailed questions about symptoms, and order blood tests to check for signs of infection or other abnormalities. These preliminary steps help rule out more common causes of swollen lymph nodes.
- 2
The definitive diagnosis requires a tissue biopsy, usually taken from an enlarged lymph node through a minor surgical procedure.
The definitive diagnosis requires a tissue biopsy, usually taken from an enlarged lymph node through a minor surgical procedure. Pathologists examine this tissue sample under a microscope to identify the characteristic large B-cells and confirm the specific subtype of lymphoma. Additional tests on the biopsy specimen, including immunohistochemistry and genetic studies, help doctors understand exactly which type of DLBCL is present and guide treatment decisions.
- 3
Once lymphoma is confirmed, staging tests determine how far the cancer has spread throughout the body.
Once lymphoma is confirmed, staging tests determine how far the cancer has spread throughout the body. These typically include: - CT scans of the chest, abdomen, and pelvis - PET scan to identify active cancer areas - Bone marrow biopsy to check for cancer cells - Lumbar puncture if brain involvement is suspected - Additional blood tests including LDH levels and hepatitis screening
Complications
- While modern treatments have greatly improved outcomes for diffuse large B-cell lymphoma, both the disease itself and its treatment can lead to various complications.
- The lymphoma may cause serious problems if it grows in critical locations such as the brain, spinal cord, or around major blood vessels.
- Rapid tumor growth can sometimes compress organs or block normal body functions, requiring immediate medical intervention.
- Treatment-related complications vary depending on the specific therapies used but often include increased infection risk due to weakened immune systems, fatigue, and potential long-term effects on heart, lung, or kidney function.
- Some patients experience peripheral neuropathy, causing numbness or tingling in hands and feet that may persist after treatment ends.
- Secondary cancers, though uncommon, can develop years later in people who received intensive chemotherapy or radiation therapy.
- Regular follow-up care helps detect and manage both short-term and long-term treatment effects while monitoring for cancer recurrence.
Prevention
- Unlike some other cancers, diffuse large B-cell lymphoma cannot be reliably prevented through lifestyle changes or screening programs because most risk factors are beyond personal control.
- Age, gender, and genetic predisposition cannot be modified, and many people who develop DLBCL have no identifiable risk factors.
- However, certain steps may help reduce overall cancer risk and support immune system health.
- Maintaining good general health through regular exercise, a balanced diet rich in fruits and vegetables, and avoiding tobacco products supports overall immune function.
- For people at higher risk due to autoimmune diseases or HIV infection, working closely with healthcare providers to manage these conditions optimally may help reduce lymphoma risk.
- Safe sex practices and avoiding sharing needles can prevent HIV and hepatitis infections that increase lymphoma likelihood.
- The most practical prevention approach involves staying alert to potential symptoms and seeking prompt medical attention for persistent, unexplained health changes.
- Regular check-ups with healthcare providers allow for early detection of concerning symptoms, and people with known risk factors should discuss appropriate monitoring strategies with their doctors.
Treatment for diffuse large B-cell lymphoma has improved dramatically over the past two decades, with most patients receiving a combination approach that targets cancer cells while supporting the body's natural defenses.
Treatment for diffuse large B-cell lymphoma has improved dramatically over the past two decades, with most patients receiving a combination approach that targets cancer cells while supporting the body's natural defenses. The standard first-line treatment involves R-CHOP chemotherapy, which combines the targeted drug rituximab with four traditional chemotherapy medications given in cycles every three weeks. This regimen cures approximately 60-70% of patients and has become the global standard of care.
For patients whose cancer returns after initial treatment or doesn't respond adequately, several second-line options exist.
For patients whose cancer returns after initial treatment or doesn't respond adequately, several second-line options exist. High-dose chemotherapy followed by stem cell transplantation offers another chance for cure in younger, healthier patients. The patient's own stem cells are collected, preserved, and then reinfused after intensive chemotherapy destroys both cancer cells and normal blood-forming cells. This approach can be highly effective but requires careful patient selection due to its intensity.
Recent advances have introduced exciting new treatment options for patients with relapsed or refractory DLBCL.
Recent advances have introduced exciting new treatment options for patients with relapsed or refractory DLBCL. CAR-T cell therapy involves removing a patient's T-cells, genetically modifying them to better recognize and attack lymphoma cells, then reinfusing these enhanced cells. This personalized approach has shown remarkable results in some patients who had exhausted other options. Additionally, newer targeted therapies and immunotherapy drugs continue to emerge from clinical trials.
Radiation therapy plays a specific role in treating DLBCL, particularly for patients with early-stage disease confined to one area or those with bulky tumors.
Radiation therapy plays a specific role in treating DLBCL, particularly for patients with early-stage disease confined to one area or those with bulky tumors. Sometimes doctors combine shorter courses of chemotherapy with radiation to reduce overall treatment intensity while maintaining effectiveness. The treatment team carefully considers factors like age, overall health, cancer stage, and patient preferences when developing individualized treatment plans.
Living With Diffuse Large B-Cell Lymphoma
Living with diffuse large B-cell lymphoma involves adapting to both the physical and emotional challenges that accompany cancer diagnosis and treatment. During active treatment, patients often need to modify daily routines to accommodate medical appointments, manage side effects like fatigue and nausea, and protect themselves from infections when immune systems are compromised. Simple strategies like frequent handwashing, avoiding crowds during flu season, and getting adequate rest become particularly important.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 10, 2026v1.0.0
- Published by DiseaseDirectory